Map2k1 antibody - C-terminal region
Product name: | Map2k1 antibody - C-terminal region |
Source: | Rabbit |
Purity: | >95% |
Buffer Formulation: | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Note: The product is for research use only,not for use in diagnostic or therapeutic procedures. Catalog Number:OM105240 Price:$325.00 Discount Price Size: Store:In stock |
Applications: | WB |
Storage: | Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles |
UOM: | 100ug |
Rabbit anti-Map2k1 polyclonal antibody - C-terminal region
Catalog Number:IC118685
Product Profile
Product Name | Rabbit anti-Map2k1 polyclonal antibody - C-terminal region |
---|---|
Antibody Type | Primary Antibodies |
Key Feature
Clonality | Polyclonal |
---|---|
Isotype | IgG |
Host Species | Rabbit |
Tested Applications | |
Species Reactivity | |
Concentration | 1mg/ml |
Purification | Affinity purified |
Target Information
Gene Symbol | Map2k1 |
---|---|
Gene Synonyms |
MAPKK1
More
MEKK1 Mek1 Prkmk1 |
Gene Full Name | Mitogen-activated protein kinase kinase 1 |
Gene Summary |
The function of this protein remains unknown.
|
Alternative Names |
MAPKK1
More
MEKK1 Mek1 Prkmk1 |
Molecular Weight(MW) | 43kDa |
Sequence | 393 amino acids |
Database Links
Entrez Gene | 26395 |
---|---|
SwissProt ID | Q9JJE1 |
Protein Accession | NP_032953 |
Application
-
Western blot
Sample Type: 1. and 2. Human Cystic Fibrosis Bronchial Epithelial Cells (35ug)Primary Dilution: 1:500Secondary Anitbody: goat anti-rabbit-HRPSecondary Dilution: 1:5000Image Submitted By: Dr. Haouaria BalghiMcGill University
-
Western blot
Map2k1 antibody - C-terminal region validated by WB using Mouse Small Intestine Lysate at 1ug/ml.
Additional Information
Form | Liquid |
---|---|
Storage Instructions | Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles |
Storage Buffer | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
Note: The product is for research use only,not for use in diagnostic or therapeutic procedures.